The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential

Clinical and Experimental Metastasis

Volumn 22, Issue 8, 2005, Pages 621-628

  Castro, Tammy A ^a   Cohen, Marion C ^b   Rameshwar, Pranela ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow metastasis; Breast cancer; Early metastasis; Neurokinin 1; Preprotachykinin 1; Substance P

Indexed keywords

NEUROKININ; NEUROKININ 1; NEUROKININ 2; PHORBOL ESTER; PREPROTACHYKININ; PREPROTACHYKININ 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER MODEL; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CLONOGENIC ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MOUSE; NK 1 GENE; NK 2 GENE; NONHUMAN; NUDE MOUSE; PPT I GENE; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACHYKININS;

EID: 33747451723     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9001-6     Document Type: Article

References (31)

1. Stockler M, Wilcken NR, Ghersi D et al. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000; 26: 151-68.
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. CA: Cancer J Clin 2003; 53: 27-43.
3. Ferlay J, Bray F, Pisani P et al. Cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press. GLOBOCAN 2000; 2001.
4. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342: 525-33.
5. Moharita A, Harrison JS, Rameshwar P.. Neurokinin and subtypes as potential targets in breast cancer: Relevance to bone marrow metastasis. Drug Des Rev Online 2004; 1: 297-302.
6. Mansi JL, Berger U, McDonnell T et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989; 7: 445-9.
7. Rao G, Patel PS, Idler SP et al. Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal comparment of the bone marrow: A model of early cancer progression. Cancer Res 2004; 64: 2874-81.
8. Satake H, Kawada T, Nomoto K et al. Insight into tachykinin-related peptides, their receptors, and invertebrate tachykinins, a review. Zoological Sci 2003; 20: 533-49.
9. Rameshwar P, Poddar A, Gascon P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymph 1997; 28: 1-10.
10. Nussdorfer GG, Malendowicz LK. Role of tachykinins in the regulation of the hypothalamus-pituitary-adrenal axis. Peptides 1998; 19: 949-68.
11. Maggio JE. Tachykinins. Annu Rev Neurosci 1988; 11: 13-28.
12. Harmar AJ, Amstrong A, Pascall JC et al. cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Lett 1986; 208: 67-72.
13. Ho WZ, Lai JP, Zhu XH et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997; 159: 5654-60.
14. Patacchini R, Maggi CA. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn 1995; 329: 161-84.
15. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994; 46: 551-99.
16. Bandari PS, Qian J, Oh HS et al. Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: Cloning and characterization of neurokin-2 promoter. J Neuroimmunol 2003; 138: 65-75.
17. Singh D, Joshi DD, Hameed M et al. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci USA 2000; 4: 388-93.
18. Henning IM, Laissue JA, Horisberger U et al. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 1995; 61: 786.
19. Soule HD, Vazuez J, Long A et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409-16.
20. Price JE. The biology of metastatic breast cancer. Cancer 1990; 66: 1313-20.
21. Thompson EW, Paik S, Brunner N et al. J Cell Physiol 1992; 150: 534-44.
22. Clarke R, Brunner N, Katzenellenbogen BS et al. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci USA 1989; 86: 3649-53.
23. Brunner N, Frandsen TL, Holst-Hansen C et al. MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI. 182,780. Cancer Res 1993; 53: 3229-32.
24. Thompson EW, Brunner N, Torri J et al. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis 1993; 11: 15-26.
25. Bandari PS, Qian J, Yehia G et al. Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cells. Neuropeptides 2001; 36: 13-21.
26. Dery O, Defea KA, Bunnett NW. Protein kinase C-mediated desensitization of the neurokinin 1 receptor. Am J Physiol Cell Physiol 2001; 280: 1097-106.
27. Greco SJ, Corcoran KE, Cho KJ, Rameshwar P. Tachykinins in the emerging immune system: Relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Frontiers in Biosci 2004; 9: 1782-93.
28. Patel H, Ramkissoon SH, Patel PS, Rameshwar P. Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-I peptides. Proc Natl Acad Sci USA 2005; 102: 17436-441.
29. Haines KA, Kolasinski SL, Cronstein BN et al. Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling. J Immunol 1993; 151: 1491-99.
30. Qian J, Yehia G, Molina C et al. Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5′-monophosphate response elements in its expression by IL-1 and stem cell factor. J Immunol 2001; 166: 2553-61.
31. Conlon NJ, Larhammar D. The evolution of neuroendocrine peptides. Gen Comp Endocrinol 2005; 142: 53-9.